Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Flavonoids | 7 | 2023 | 443 | 2.800 |
Why?
|
| Veterans | 6 | 2024 | 2519 | 1.430 |
Why?
|
| Diet | 20 | 2024 | 7939 | 1.280 |
Why?
|
| Yogurt | 5 | 2021 | 72 | 0.950 |
Why?
|
| Trans Fatty Acids | 1 | 2023 | 153 | 0.840 |
Why?
|
| Diet Surveys | 4 | 2021 | 1173 | 0.830 |
Why?
|
| Probiotics | 2 | 2014 | 351 | 0.740 |
Why?
|
| Food Analysis | 2 | 2017 | 104 | 0.720 |
Why?
|
| Nuts | 1 | 2021 | 257 | 0.680 |
Why?
|
| Flavonols | 2 | 2020 | 83 | 0.630 |
Why?
|
| Feeding Behavior | 8 | 2020 | 3188 | 0.570 |
Why?
|
| Cardiovascular Diseases | 8 | 2023 | 15165 | 0.560 |
Why?
|
| Mortality | 3 | 2017 | 2864 | 0.550 |
Why?
|
| Leptin | 2 | 2023 | 1599 | 0.530 |
Why?
|
| Antithyroid Agents | 1 | 2014 | 70 | 0.490 |
Why?
|
| Proanthocyanidins | 1 | 2013 | 20 | 0.470 |
Why?
|
| Camellia sinensis | 1 | 2013 | 8 | 0.460 |
Why?
|
| Overweight | 3 | 2018 | 2371 | 0.450 |
Why?
|
| Atherosclerosis | 2 | 2023 | 3445 | 0.440 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2023 | 11725 | 0.430 |
Why?
|
| Western Australia | 4 | 2017 | 41 | 0.410 |
Why?
|
| Tunica Media | 1 | 2011 | 113 | 0.390 |
Why?
|
| Nutrition Assessment | 4 | 2020 | 723 | 0.390 |
Why?
|
| Feces | 5 | 2021 | 1401 | 0.380 |
Why?
|
| Carotid Artery, Common | 1 | 2011 | 183 | 0.370 |
Why?
|
| Hypolipidemic Agents | 1 | 2014 | 604 | 0.350 |
Why?
|
| Plant Extracts | 1 | 2013 | 471 | 0.350 |
Why?
|
| Fruit | 4 | 2023 | 1142 | 0.350 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 789 | 0.340 |
Why?
|
| Dietary Supplements | 2 | 2019 | 3297 | 0.330 |
Why?
|
| Tunica Intima | 1 | 2011 | 464 | 0.330 |
Why?
|
| Vegetables | 3 | 2021 | 1182 | 0.320 |
Why?
|
| Health Surveys | 2 | 2020 | 4037 | 0.310 |
Why?
|
| Aged | 30 | 2024 | 163280 | 0.310 |
Why?
|
| Dairy Products | 1 | 2011 | 498 | 0.300 |
Why?
|
| Life Style | 6 | 2022 | 3835 | 0.290 |
Why?
|
| Environmental Exposure | 1 | 2021 | 4234 | 0.280 |
Why?
|
| Lactobacillus acidophilus | 2 | 2014 | 21 | 0.250 |
Why?
|
| Diet Records | 3 | 2021 | 425 | 0.240 |
Why?
|
| Milk | 2 | 2021 | 450 | 0.240 |
Why?
|
| Prospective Studies | 16 | 2023 | 53288 | 0.240 |
Why?
|
| Lipids | 3 | 2021 | 3305 | 0.230 |
Why?
|
| Methylamines | 2 | 2021 | 123 | 0.220 |
Why?
|
| Celiac Disease | 2 | 2021 | 785 | 0.210 |
Why?
|
| Lignans | 1 | 2022 | 81 | 0.200 |
Why?
|
| Aged, 80 and over | 12 | 2023 | 57776 | 0.200 |
Why?
|
| Middle Aged | 23 | 2023 | 213383 | 0.190 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 2538 | 0.190 |
Why?
|
| Haemophilus Infections | 1 | 2020 | 95 | 0.190 |
Why?
|
| Flavones | 1 | 2020 | 66 | 0.190 |
Why?
|
| Follow-Up Studies | 14 | 2023 | 39050 | 0.180 |
Why?
|
| Anthocyanins | 1 | 2020 | 79 | 0.180 |
Why?
|
| Tea | 2 | 2023 | 275 | 0.180 |
Why?
|
| Glutens | 2 | 2021 | 230 | 0.180 |
Why?
|
| Chemical Fractionation | 1 | 2020 | 65 | 0.180 |
Why?
|
| Female | 32 | 2024 | 380194 | 0.180 |
Why?
|
| Humans | 49 | 2024 | 744343 | 0.180 |
Why?
|
| Risk Factors | 14 | 2023 | 72290 | 0.180 |
Why?
|
| Bacterial Load | 1 | 2020 | 153 | 0.170 |
Why?
|
| Risk Assessment | 1 | 2021 | 23338 | 0.170 |
Why?
|
| Adiponectin | 2 | 2023 | 1100 | 0.170 |
Why?
|
| Male | 32 | 2024 | 350118 | 0.170 |
Why?
|
| Food | 2 | 2024 | 771 | 0.170 |
Why?
|
| Stroke | 1 | 2021 | 9981 | 0.160 |
Why?
|
| Metagenome | 2 | 2021 | 418 | 0.160 |
Why?
|
| Factor Analysis, Statistical | 1 | 2021 | 977 | 0.160 |
Why?
|
| Statistics, Nonparametric | 2 | 2021 | 2886 | 0.150 |
Why?
|
| Weight Loss | 2 | 2020 | 2622 | 0.150 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 768 | 0.150 |
Why?
|
| Colitis, Ulcerative | 2 | 2021 | 1912 | 0.150 |
Why?
|
| United States | 8 | 2023 | 69872 | 0.150 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2018 | 147 | 0.150 |
Why?
|
| Kidney | 1 | 2013 | 7186 | 0.150 |
Why?
|
| Beverages | 1 | 2023 | 820 | 0.150 |
Why?
|
| Dietary Fiber | 1 | 2021 | 760 | 0.150 |
Why?
|
| Ear, Middle | 1 | 2019 | 334 | 0.150 |
Why?
|
| Wine | 1 | 2017 | 165 | 0.140 |
Why?
|
| United States Department of Agriculture | 1 | 2016 | 48 | 0.140 |
Why?
|
| Specimen Handling | 1 | 2021 | 694 | 0.140 |
Why?
|
| Multivariate Analysis | 3 | 2021 | 12245 | 0.140 |
Why?
|
| Nitrates | 1 | 2017 | 265 | 0.130 |
Why?
|
| Malus | 1 | 2016 | 48 | 0.130 |
Why?
|
| Adult | 19 | 2023 | 214055 | 0.130 |
Why?
|
| Caloric Restriction | 1 | 2018 | 302 | 0.130 |
Why?
|
| Nutritional Status | 1 | 2024 | 1609 | 0.130 |
Why?
|
| Fatty Acids | 1 | 2023 | 1809 | 0.130 |
Why?
|
| Dietary Fats | 1 | 2023 | 2017 | 0.130 |
Why?
|
| Milk, Human | 1 | 2020 | 490 | 0.130 |
Why?
|
| Incidence | 7 | 2021 | 20947 | 0.130 |
Why?
|
| DNA, Bacterial | 1 | 2020 | 1465 | 0.120 |
Why?
|
| Bacteria | 3 | 2020 | 2114 | 0.120 |
Why?
|
| Databases as Topic | 1 | 2016 | 475 | 0.120 |
Why?
|
| Hypertension | 1 | 2014 | 8480 | 0.120 |
Why?
|
| Bifidobacterium | 1 | 2014 | 100 | 0.120 |
Why?
|
| Bacillus | 1 | 2014 | 77 | 0.120 |
Why?
|
| Australia | 3 | 2023 | 1170 | 0.110 |
Why?
|
| Insulin Resistance | 2 | 2018 | 3864 | 0.110 |
Why?
|
| Intraocular Pressure | 1 | 2018 | 1270 | 0.100 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 1889 | 0.100 |
Why?
|
| Asthma | 2 | 2021 | 6011 | 0.100 |
Why?
|
| Metabolomics | 1 | 2020 | 1484 | 0.100 |
Why?
|
| Superoxides | 1 | 1993 | 387 | 0.100 |
Why?
|
| Metagenomics | 3 | 2021 | 428 | 0.100 |
Why?
|
| Cheese | 1 | 2011 | 38 | 0.100 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2018 | 706 | 0.100 |
Why?
|
| Cystic Fibrosis | 1 | 2020 | 1177 | 0.100 |
Why?
|
| Regression Analysis | 1 | 2021 | 6459 | 0.100 |
Why?
|
| Phytotherapy | 1 | 2013 | 298 | 0.100 |
Why?
|
| Carotid Artery Diseases | 1 | 2017 | 882 | 0.090 |
Why?
|
| Occupational Exposure | 1 | 2021 | 1796 | 0.090 |
Why?
|
| Cerebrovascular Disorders | 1 | 2017 | 1504 | 0.090 |
Why?
|
| Double-Blind Method | 2 | 2014 | 12026 | 0.090 |
Why?
|
| Gastric Mucosa | 1 | 1993 | 599 | 0.090 |
Why?
|
| Proton Pump Inhibitors | 1 | 2014 | 526 | 0.090 |
Why?
|
| Hydrogen Peroxide | 1 | 1993 | 731 | 0.090 |
Why?
|
| Neoplasms | 2 | 2016 | 21683 | 0.090 |
Why?
|
| Dementia | 1 | 2023 | 2518 | 0.080 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 19905 | 0.080 |
Why?
|
| Hemoglobins | 1 | 2014 | 1534 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 7181 | 0.080 |
Why?
|
| Proportional Hazards Models | 3 | 2019 | 12354 | 0.070 |
Why?
|
| Accidental Falls | 1 | 2014 | 1062 | 0.070 |
Why?
|
| Insulin | 3 | 2018 | 6580 | 0.070 |
Why?
|
| Eating | 1 | 2013 | 1536 | 0.070 |
Why?
|
| Body Mass Index | 2 | 2014 | 12720 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 2425 | 0.070 |
Why?
|
| Exercise | 1 | 2022 | 5615 | 0.070 |
Why?
|
| Postmenopause | 1 | 2014 | 2461 | 0.070 |
Why?
|
| Glomerular Filtration Rate | 1 | 2013 | 2170 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2021 | 8554 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 9438 | 0.060 |
Why?
|
| Energy Intake | 2 | 2024 | 2148 | 0.060 |
Why?
|
| Gene Expression | 1 | 2018 | 7799 | 0.060 |
Why?
|
| Iron | 1 | 1993 | 1774 | 0.060 |
Why?
|
| Cholesterol, HDL | 1 | 2011 | 1814 | 0.060 |
Why?
|
| Inflammation | 2 | 2021 | 10638 | 0.060 |
Why?
|
| Blood Glucose | 2 | 2018 | 6256 | 0.060 |
Why?
|
| Patient Compliance | 1 | 2014 | 2684 | 0.060 |
Why?
|
| Kynurenine | 1 | 2023 | 139 | 0.060 |
Why?
|
| Fractures, Bone | 1 | 2014 | 1947 | 0.050 |
Why?
|
| Young Adult | 4 | 2021 | 56430 | 0.050 |
Why?
|
| 4-Butyrolactone | 1 | 2022 | 63 | 0.050 |
Why?
|
| Health Personnel | 3 | 2021 | 3218 | 0.050 |
Why?
|
| Tryptophan | 1 | 2023 | 478 | 0.050 |
Why?
|
| Nova Scotia | 1 | 2020 | 34 | 0.050 |
Why?
|
| Shellfish | 1 | 2020 | 38 | 0.050 |
Why?
|
| Prevotella | 1 | 2021 | 79 | 0.050 |
Why?
|
| Risk | 1 | 2013 | 9687 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2013 | 9849 | 0.050 |
Why?
|
| Clarithromycin | 1 | 2020 | 86 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 9959 | 0.050 |
Why?
|
| Haemophilus influenzae | 1 | 2020 | 171 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 6773 | 0.040 |
Why?
|
| Diet, Vegetarian | 1 | 2021 | 174 | 0.040 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2011 | 1519 | 0.040 |
Why?
|
| Choline | 1 | 2021 | 493 | 0.040 |
Why?
|
| Sulfur | 1 | 2020 | 166 | 0.040 |
Why?
|
| Azithromycin | 1 | 2020 | 196 | 0.040 |
Why?
|
| Ear, External | 1 | 2019 | 161 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2019 | 40561 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2022 | 676 | 0.040 |
Why?
|
| Micronutrients | 1 | 2021 | 375 | 0.040 |
Why?
|
| Animals | 4 | 2021 | 168757 | 0.040 |
Why?
|
| Fishes | 1 | 2020 | 569 | 0.040 |
Why?
|
| Receptors, Leptin | 1 | 2018 | 360 | 0.040 |
Why?
|
| C-Peptide | 1 | 2018 | 419 | 0.040 |
Why?
|
| Prognosis | 2 | 2018 | 29063 | 0.040 |
Why?
|
| Nasopharynx | 1 | 2019 | 379 | 0.040 |
Why?
|
| Musa | 1 | 2016 | 12 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2023 | 1035 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 954 | 0.030 |
Why?
|
| Diet, Fat-Restricted | 1 | 2018 | 320 | 0.030 |
Why?
|
| Age Factors | 2 | 2023 | 18370 | 0.030 |
Why?
|
| Mental Recall | 1 | 2021 | 1205 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2020 | 1877 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1782 | 0.030 |
Why?
|
| Diet, Mediterranean | 1 | 2021 | 700 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2018 | 917 | 0.030 |
Why?
|
| Glucose Oxidase | 1 | 1993 | 19 | 0.030 |
Why?
|
| Phenanthrolines | 1 | 1993 | 55 | 0.030 |
Why?
|
| Catalase | 1 | 1993 | 222 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2018 | 2297 | 0.030 |
Why?
|
| Deferoxamine | 1 | 1993 | 151 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2022 | 2703 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 1889 | 0.030 |
Why?
|
| Age Distribution | 1 | 2018 | 2902 | 0.030 |
Why?
|
| Fasting | 1 | 2018 | 1593 | 0.030 |
Why?
|
| Allopurinol | 1 | 1993 | 191 | 0.030 |
Why?
|
| Nurses | 1 | 2021 | 2461 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2022 | 15519 | 0.020 |
Why?
|
| Phylogeny | 1 | 2018 | 2803 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 1993 | 597 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 3778 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 25043 | 0.020 |
Why?
|
| Women's Health | 1 | 2019 | 2034 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 1708 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 4803 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2021 | 41006 | 0.020 |
Why?
|
| Sex Factors | 1 | 2021 | 10397 | 0.020 |
Why?
|
| Massachusetts | 1 | 2020 | 8663 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2018 | 2063 | 0.020 |
Why?
|
| Hospitalization | 2 | 2017 | 10262 | 0.020 |
Why?
|
| Stem Cells | 1 | 2019 | 3567 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2021 | 9146 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3597 | 0.020 |
Why?
|
| Genotype | 1 | 2018 | 12951 | 0.010 |
Why?
|
| Disease Progression | 1 | 2020 | 13284 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 12261 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 7785 | 0.010 |
Why?
|
| Prevalence | 1 | 2019 | 15226 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1993 | 8301 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 13989 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1993 | 19229 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20129 | 0.010 |
Why?
|
| Rats | 1 | 1993 | 24260 | 0.010 |
Why?
|
| Obesity | 1 | 2018 | 12745 | 0.010 |
Why?
|
| Mutation | 1 | 2018 | 29786 | 0.010 |
Why?
|
| Child | 1 | 2021 | 77709 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 40075 | 0.010 |
Why?
|
| Adolescent | 1 | 2020 | 85781 | 0.010 |
Why?
|
Concepts
(220)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(68)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_